3.26.1 html 127 241 1 false 48 0 false 5 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.beyondspringpharma.com/20260331/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) Sheet http://www.beyondspringpharma.com/20260331/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited Condensed Consolidated Balance Sheets (Current Period Unaudited) Statements 2 false false R3.htm 002 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Sheet http://www.beyondspringpharma.com/20260331/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) Sheet http://www.beyondspringpharma.com/20260331/role/statement-condensed-consolidated-statements-of-comprehensive-income-loss-unaudited Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) Statements 4 false false R5.htm 004 - Statement - Condensed Consolidated Statements of Shareholders' Deficit (Unaudited) Sheet http://www.beyondspringpharma.com/20260331/role/statement-condensed-consolidated-statements-of-shareholders-deficit-unaudited Condensed Consolidated Statements of Shareholders' Deficit (Unaudited) Statements 5 false false R6.htm 005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.beyondspringpharma.com/20260331/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 006 - Disclosure - Note 1 - Nature of the Business and the Basis of Preparation Sheet http://www.beyondspringpharma.com/20260331/role/statement-note-1-nature-of-the-business-and-the-basis-of-preparation Note 1 - Nature of the Business and the Basis of Preparation Notes 7 false false R8.htm 007 - Disclosure - Note 2 - Summary of Significant Accounting Policies Sheet http://www.beyondspringpharma.com/20260331/role/statement-note-2-summary-of-significant-accounting-policies Note 2 - Summary of Significant Accounting Policies Notes 8 false false R9.htm 008 - Disclosure - Note 3 - Discontinued Operations Sheet http://www.beyondspringpharma.com/20260331/role/statement-note-3-discontinued-operations Note 3 - Discontinued Operations Notes 9 false false R10.htm 009 - Disclosure - Note 4 - Collaboration Agreements Sheet http://www.beyondspringpharma.com/20260331/role/statement-note-4-collaboration-agreements Note 4 - Collaboration Agreements Notes 10 false false R11.htm 010 - Disclosure - Note 5 - Property and Equipment, Net Sheet http://www.beyondspringpharma.com/20260331/role/statement-note-5-property-and-equipment-net Note 5 - Property and Equipment, Net Notes 11 false false R12.htm 011 - Disclosure - Note 6 - Income Taxes Sheet http://www.beyondspringpharma.com/20260331/role/statement-note-6-income-taxes Note 6 - Income Taxes Notes 12 false false R13.htm 012 - Disclosure - Note 7 - Earnings (Loss) Per Share Sheet http://www.beyondspringpharma.com/20260331/role/statement-note-7-earnings-loss-per-share Note 7 - Earnings (Loss) Per Share Notes 13 false false R14.htm 013 - Disclosure - Note 8 - Share-based Compensation Sheet http://www.beyondspringpharma.com/20260331/role/statement-note-8-sharebased-compensation Note 8 - Share-based Compensation Notes 14 false false R15.htm 014 - Disclosure - Note 9 - Employee Defined Contribution Plan Sheet http://www.beyondspringpharma.com/20260331/role/statement-note-9-employee-defined-contribution-plan- Note 9 - Employee Defined Contribution Plan Notes 15 false false R16.htm 015 - Disclosure - Note 10 - Restricted Net Assets Sheet http://www.beyondspringpharma.com/20260331/role/statement-note-10-restricted-net-assets Note 10 - Restricted Net Assets Notes 16 false false R17.htm 016 - Disclosure - Note 11 - Supplemental Balance Sheet Information Sheet http://www.beyondspringpharma.com/20260331/role/statement-note-11-supplemental-balance-sheet-information Note 11 - Supplemental Balance Sheet Information Notes 17 false false R18.htm 017 - Disclosure - Note 12 - Noncontrolling Interests Sheet http://www.beyondspringpharma.com/20260331/role/statement-note-12-noncontrolling-interests- Note 12 - Noncontrolling Interests Notes 18 false false R19.htm 018 - Disclosure - Note 13 - Commitments and Contingencies Sheet http://www.beyondspringpharma.com/20260331/role/statement-note-13-commitments-and-contingencies Note 13 - Commitments and Contingencies Notes 19 false false R20.htm 019 - Disclosure - Note 14 - Segment Reporting and Geographic Information Sheet http://www.beyondspringpharma.com/20260331/role/statement-note-14-segment-reporting-and-geographic-information Note 14 - Segment Reporting and Geographic Information Notes 20 false false R21.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 21 false false R22.htm 995445 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.beyondspringpharma.com/20260331/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Policies http://www.beyondspringpharma.com/20260331/role/statement-note-2-summary-of-significant-accounting-policies 22 false false R23.htm 995446 - Disclosure - Note 1 - Nature of the Business and the Basis of Preparation (Tables) Sheet http://www.beyondspringpharma.com/20260331/role/statement-note-1-nature-of-the-business-and-the-basis-of-preparation-tables Note 1 - Nature of the Business and the Basis of Preparation (Tables) Tables http://www.beyondspringpharma.com/20260331/role/statement-note-1-nature-of-the-business-and-the-basis-of-preparation 23 false false R24.htm 995447 - Disclosure - Note 3 - Discontinued Operations (Tables) Sheet http://www.beyondspringpharma.com/20260331/role/statement-note-3-discontinued-operations-tables Note 3 - Discontinued Operations (Tables) Tables http://www.beyondspringpharma.com/20260331/role/statement-note-3-discontinued-operations 24 false false R25.htm 995448 - Disclosure - Note 5 - Property and Equipment, Net (Tables) Sheet http://www.beyondspringpharma.com/20260331/role/statement-note-5-property-and-equipment-net-tables Note 5 - Property and Equipment, Net (Tables) Tables http://www.beyondspringpharma.com/20260331/role/statement-note-5-property-and-equipment-net 25 false false R26.htm 995449 - Disclosure - Note 7 - Earnings (Loss) Per Share (Tables) Sheet http://www.beyondspringpharma.com/20260331/role/statement-note-7-earnings-loss-per-share-tables Note 7 - Earnings (Loss) Per Share (Tables) Tables http://www.beyondspringpharma.com/20260331/role/statement-note-7-earnings-loss-per-share 26 false false R27.htm 995450 - Disclosure - Note 8 - Share-based Compensation (Tables) Sheet http://www.beyondspringpharma.com/20260331/role/statement-note-8-sharebased-compensation-tables Note 8 - Share-based Compensation (Tables) Tables http://www.beyondspringpharma.com/20260331/role/statement-note-8-sharebased-compensation 27 false false R28.htm 995451 - Disclosure - Note 11 - Supplemental Balance Sheet Information (Tables) Sheet http://www.beyondspringpharma.com/20260331/role/statement-note-11-supplemental-balance-sheet-information-tables Note 11 - Supplemental Balance Sheet Information (Tables) Tables http://www.beyondspringpharma.com/20260331/role/statement-note-11-supplemental-balance-sheet-information 28 false false R29.htm 995452 - Disclosure - Note 14 - Segment Reporting and Geographic Information (Tables) Sheet http://www.beyondspringpharma.com/20260331/role/statement-note-14-segment-reporting-and-geographic-information-tables Note 14 - Segment Reporting and Geographic Information (Tables) Tables http://www.beyondspringpharma.com/20260331/role/statement-note-14-segment-reporting-and-geographic-information 29 false false R30.htm 995453 - Disclosure - Note 1 - Nature of the Business and the Basis of Preparation (Details Textual) Sheet http://www.beyondspringpharma.com/20260331/role/statement-note-1-nature-of-the-business-and-the-basis-of-preparation-details-textual Note 1 - Nature of the Business and the Basis of Preparation (Details Textual) Details http://www.beyondspringpharma.com/20260331/role/statement-note-1-nature-of-the-business-and-the-basis-of-preparation-tables 30 false false R31.htm 995454 - Disclosure - Note 1 - Nature of the Business and the Basis of Preparation - Schedule of Subsidiaries (Details) Sheet http://www.beyondspringpharma.com/20260331/role/statement-note-1-nature-of-the-business-and-the-basis-of-preparation-schedule-of-subsidiaries-details Note 1 - Nature of the Business and the Basis of Preparation - Schedule of Subsidiaries (Details) Details 31 false false R32.htm 995455 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details Textual) Sheet http://www.beyondspringpharma.com/20260331/role/statement-note-2-summary-of-significant-accounting-policies-details-textual Note 2 - Summary of Significant Accounting Policies (Details Textual) Details 32 false false R33.htm 995456 - Disclosure - Note 3 - Discontinued Operations (Details Textual) Sheet http://www.beyondspringpharma.com/20260331/role/statement-note-3-discontinued-operations-details-textual Note 3 - Discontinued Operations (Details Textual) Details http://www.beyondspringpharma.com/20260331/role/statement-note-3-discontinued-operations-tables 33 false false R34.htm 995457 - Disclosure - Note 3 - Discontinued Operations - Summary of Discontinued Operations (Details) Sheet http://www.beyondspringpharma.com/20260331/role/statement-note-3-discontinued-operations-summary-of-discontinued-operations-details Note 3 - Discontinued Operations - Summary of Discontinued Operations (Details) Details 34 false false R35.htm 995458 - Disclosure - Note 3 - Discontinued Operations - Summary of Discontinued Operations (Details) (Parentheticals) Sheet http://www.beyondspringpharma.com/20260331/role/statement-note-3-discontinued-operations-summary-of-discontinued-operations-details-parentheticals Note 3 - Discontinued Operations - Summary of Discontinued Operations (Details) (Parentheticals) Details 35 false false R36.htm 995459 - Disclosure - Note 4 - Collaboration Agreements (Details Textual) Sheet http://www.beyondspringpharma.com/20260331/role/statement-note-4-collaboration-agreements-details-textual Note 4 - Collaboration Agreements (Details Textual) Details http://www.beyondspringpharma.com/20260331/role/statement-note-4-collaboration-agreements 36 false false R37.htm 995460 - Disclosure - Note 5 - Property and Equipment, Net (Details Textual) Sheet http://www.beyondspringpharma.com/20260331/role/statement-note-5-property-and-equipment-net-details-textual Note 5 - Property and Equipment, Net (Details Textual) Details http://www.beyondspringpharma.com/20260331/role/statement-note-5-property-and-equipment-net-tables 37 false false R38.htm 995461 - Disclosure - Note 5 - Property and Equipment, Net - Schedule of Property and Equipment (Details) Sheet http://www.beyondspringpharma.com/20260331/role/statement-note-5-property-and-equipment-net-schedule-of-property-and-equipment-details Note 5 - Property and Equipment, Net - Schedule of Property and Equipment (Details) Details 38 false false R39.htm 995462 - Disclosure - Note 6 - Income Taxes (Details Textual) Sheet http://www.beyondspringpharma.com/20260331/role/statement-note-6-income-taxes-details-textual Note 6 - Income Taxes (Details Textual) Details http://www.beyondspringpharma.com/20260331/role/statement-note-6-income-taxes 39 false false R40.htm 995463 - Disclosure - Note 7 - Earnings (Loss) Per Share - Schedule of Earnings Per Share, Basic and Diluted (Details) Sheet http://www.beyondspringpharma.com/20260331/role/statement-note-7-earnings-loss-per-share-schedule-of-earnings-per-share-basic-and-diluted-details Note 7 - Earnings (Loss) Per Share - Schedule of Earnings Per Share, Basic and Diluted (Details) Details http://www.beyondspringpharma.com/20260331/role/statement-note-7-earnings-loss-per-share-tables 40 false false R41.htm 995464 - Disclosure - Note 8 - Share-based Compensation (Details Textual) Sheet http://www.beyondspringpharma.com/20260331/role/statement-note-8-sharebased-compensation-details-textual Note 8 - Share-based Compensation (Details Textual) Details http://www.beyondspringpharma.com/20260331/role/statement-note-8-sharebased-compensation-tables 41 false false R42.htm 995465 - Disclosure - Note 8 - Share-based Compensation - Share-based Compensation Expense (Details) Sheet http://www.beyondspringpharma.com/20260331/role/statement-note-8-sharebased-compensation-sharebased-compensation-expense-details Note 8 - Share-based Compensation - Share-based Compensation Expense (Details) Details 42 false false R43.htm 995466 - Disclosure - Note 9 - Employee Defined Contribution Plan (Details Textual) Sheet http://www.beyondspringpharma.com/20260331/role/statement-note-9-employee-defined-contribution-plan-details-textual Note 9 - Employee Defined Contribution Plan (Details Textual) Details http://www.beyondspringpharma.com/20260331/role/statement-note-9-employee-defined-contribution-plan- 43 false false R44.htm 995467 - Disclosure - Note 10 - Restricted Net Assets (Details Textual) Sheet http://www.beyondspringpharma.com/20260331/role/statement-note-10-restricted-net-assets-details-textual Note 10 - Restricted Net Assets (Details Textual) Details http://www.beyondspringpharma.com/20260331/role/statement-note-10-restricted-net-assets 44 false false R45.htm 995468 - Disclosure - Note 11 - Supplemental Balance Sheet Information - Other Noncurrent Assets (Details) Sheet http://www.beyondspringpharma.com/20260331/role/statement-note-11-supplemental-balance-sheet-information-other-noncurrent-assets-details Note 11 - Supplemental Balance Sheet Information - Other Noncurrent Assets (Details) Details 45 false false R46.htm 995469 - Disclosure - Note 11 - Supplemental Balance Sheet Information - Other Current Liabilities (Details) Sheet http://www.beyondspringpharma.com/20260331/role/statement-note-11-supplemental-balance-sheet-information-other-current-liabilities-details Note 11 - Supplemental Balance Sheet Information - Other Current Liabilities (Details) Details 46 false false R47.htm 995470 - Disclosure - Note 11 - Supplemental Balance Sheet Information - Other Noncurrent Liabilities (Details) Sheet http://www.beyondspringpharma.com/20260331/role/statement-note-11-supplemental-balance-sheet-information-other-noncurrent-liabilities-details Note 11 - Supplemental Balance Sheet Information - Other Noncurrent Liabilities (Details) Details 47 false false R48.htm 995471 - Disclosure - Note 12 - Noncontrolling Interests (Details Textual) Sheet http://www.beyondspringpharma.com/20260331/role/statement-note-12-noncontrolling-interests-details-textual Note 12 - Noncontrolling Interests (Details Textual) Details http://www.beyondspringpharma.com/20260331/role/statement-note-12-noncontrolling-interests- 48 false false R49.htm 995472 - Disclosure - Note 14 - Segment Reporting and Geographic Information (Details Textual) Sheet http://www.beyondspringpharma.com/20260331/role/statement-note-14-segment-reporting-and-geographic-information-details-textual Note 14 - Segment Reporting and Geographic Information (Details Textual) Details http://www.beyondspringpharma.com/20260331/role/statement-note-14-segment-reporting-and-geographic-information-tables 49 false false R50.htm 995473 - Disclosure - Note 14 - Segment Reporting and Geographic Information - Segment Expenses (Details) Sheet http://www.beyondspringpharma.com/20260331/role/statement-note-14-segment-reporting-and-geographic-information-segment-expenses-details Note 14 - Segment Reporting and Geographic Information - Segment Expenses (Details) Details 50 false false R51.htm 995474 - Disclosure - Note 14 - Segment Reporting and Geographic Information - Long Lived Assets by Geographic Area (Details) Sheet http://www.beyondspringpharma.com/20260331/role/statement-note-14-segment-reporting-and-geographic-information-long-lived-assets-by-geographic-area-details Note 14 - Segment Reporting and Geographic Information - Long Lived Assets by Geographic Area (Details) Details 51 false false All Reports Book All Reports bysi-20260331.xsd bysi-20260331_cal.xml bysi-20260331_def.xml bysi-20260331_lab.xml bysi-20260331_pre.xml bysi20260331_10q.htm http://fasb.org/us-gaap/2026 http://xbrl.sec.gov/dei/2026 http://xbrl.sec.gov/ecd/2026 true true